Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.
AUTOR(ES)
Anderson, J V
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1246289Documentos Relacionados
- Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.
- Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors.
- Mechanical stimulation activates Gαq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cells
- Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
- Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide